Carolin Beuker Selected Research

Carolin Beuker Research Topics

4	Ischemic Stroke 03/2024 - 01/2018
3	Infarction (Infarctions) 03/2024 - 01/2018
3	Stroke (Strokes) 01/2020 - 01/2014
3	Primary angiitis of the central nervous system 01/2020 - 01/2018
2	Hypertension (High Blood Pressure) 01/2018 - 01/2014
1	Isaacs Syndrome (Neuromyotonia) 01/2023
1	Autoimmune Diseases of the Nervous System 01/2023
1	Inflammation (Inflammations) 01/2020
1	Takayasu Arteritis (Arteritis, Takayasu's) 01/2019
1	Giant Cell Arteritis (Horton Disease) 01/2019
1	Polyarteritis Nodosa (Periarteritis Nodosa) 01/2019
1	IgA Vasculitis (Purpura, Schoenlein Henoch) 01/2019
1	Vasculitis (Vasculitides) 01/2019
1	Multiple Sclerosis 01/2018
1	Neuromyelitis Optica (Devic's Disease) 01/2018
1	Pathologic Processes 01/2018
1	Brain Injuries (Brain Injury) 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Necrosis 01/2018
1	Acute Cholecystitis 11/2016
1	Ischemia 01/2014

2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2020
1	cadherin 5IBA 03/2024
1	AutoantibodiesIBA 01/2023
1	Neuroprotective AgentsIBA 01/2020
1	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 01/2020
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Tryptophan (L-Tryptophan)FDA Link 01/2018
1	Rituximab (Mabthera)FDA Link 01/2018
1	SaltsIBA 01/2018
1	Sodium Chloride FDA LinkGeneric 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Alemtuzumab (Campath)FDA Link 11/2016
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2014